Differentiation of nonalcoholic from alcoholic steatohepatitis: Are routine laboratory markers useful?

Wiener Klinische Wochenschrift

Volumn 120, Issue 1-2, 2008, Pages 25-30

  Kazemi Shirazi, Lili ^a   Veloso, Moema Pinheiro ^a   Frommlet, Florian ^a   Steindl Munda, Petra ^a   Wrba, Fritz ^a   Zehetmayer, Sonja ^a   Marsik, Claudia ^a   Ferenci, Peter ^a  

^a MEDICAL UNIVERSITY OF VIENNA   (Austria)

Author keywords

ASH; AST ALT ratio; Biomarkers; Differential diagnosis; MCV; NASH

Indexed keywords

ALANINE AMINOTRANSFERASE; ALCOHOL; ASPARTATE AMINOTRANSFERASE; BIOLOGICAL MARKER;

ADOLESCENT; ADULT; AGED; ALCOHOL CONSUMPTION; ALCOHOLIC FATTY LIVER; ARTICLE; CONTROLLED STUDY; DIFFERENTIAL DIAGNOSIS; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; LABORATORY TEST; LIVER BIOPSY; LIVER FIBROSIS; LOGISTIC REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE ANALYSIS OF VARIANCE; NONALCOHOLIC FATTY LIVER;

ADOLESCENT; ADULT; AGED; ALANINE TRANSAMINASE; ASPARTATE AMINOTRANSFERASES; BIOLOGICAL MARKERS; BIOPSY; DIAGNOSIS, DIFFERENTIAL; ERYTHROCYTE INDICES; FATTY LIVER; FATTY LIVER, ALCOHOLIC; FEMALE; HUMANS; LIVER; LIVER CIRRHOSIS; LIVER CIRRHOSIS, ALCOHOLIC; LIVER FUNCTION TESTS; MALE; MIDDLE AGED; PREDICTIVE VALUE OF TESTS; RETROSPECTIVE STUDIES;

EID: 38949199685     PISSN: 00435325     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00508-007-0921-1     Document Type: Article

References (36)

1. Byron D, Minuk GY (1996) Profile of an urban, hospital-based practice. Hepatology 24: 813-815
2. Powell EE, Cooksley WG, Hanson R, Searle J, Halliday JW, Powell LW (1990) The natural history of nonalcoholic steatohepatitis: a follow-up study of 42 patients for up to 21 years. Hepatology 11: 74-80
3. Caldwell SH, Oelsner DH, Iezzoni JC, Hespenheide EE, Battle EH, Driscoll CJ (1999) Cryptogenic cirrhosis: clinical characterization and risk factors for underlying disease. Hepatology 29: 664-669
4. Marchesini G, Brizi M, Bianchi G, Tomassetti S, Bugianesi E, Lenzi M, et al (2001) Non-alcoholic fatty liver disease. A feature of the metabolic syndrome. Diabetes 50: 1844-1850
5. Itoh S, Yougel T, Kawagoe K (1987) Comparison between nonalcoholic steatohepatitis and alcoholic hepatitis. Am J Gastroenterol 82: 650-654
6. Diehl AM, Goodman Z, Ishak KG (1988) Alcohol-like liver disease in nonalcoholics. A clinical and histologic comparison with alcohol-induced liver injury. Gastroenterology 95: 1056-1062
7. Fletcher LM, Kwoh-Gain I, Powell EE, Powell LW, Halliday JW (1991) Markers of chronic alcohol ingestion in patients with nonalcoholic steatohepatitis: an aid to diagnosis. Hepatology 13: 455-459
8. Pinto HC, Baptista A, Camilo ME, Valente A, Saragoca A, de Moura MC (1996) Nonalcoholic steatohepatitis. Clinicopathological comparison with alcoholic hepatitis in ambulatory and hospitalized patients. Dig Dis Sci 41: 172-179
9. Sorbi D, Boynton J, Lindor KD (1999) The ratio of aspartate aminotransferase to alanine aminotransferase: potential value in differentiating nonalcoholic steatohepatitis from alcoholic liver disease. Am J Gastroenterol 94: 1018-1022
10. Brunt EM (2001) Nonalcoholic steatohepatitis. Definition and pathology. Semin Liver Dis 21: 3-16
11. Sanderson SO, Smyrk TC (2005) The use of protein tyrosine phosphatase 1B and insulin receptor immunostains to differentiate nonalcoholic from alcoholic steatohepatitis in liver biopsy specimens. Am J Clin Pathol 123: 503-509
12. Lumeng L (1986) New diagnostic markers of alcohol abuse. Hepatology 6: 742-745
13. Chick J, Erickson CK (1996) Conference summary: Consensus conference on alcohol dependence and the role of pharmacotherapy in its treatment. Alcohol Clin Exp Res 20: 391-402
14. McCullough AJ, O'Connor JF (1998) Alcoholic liver disease: proposed recommendations for the American College of Gastroenterology. Am J Gastroenterol 93: 2022-2036
15. Matteoni CA, Younossi ZM, Gramlich T, Boparai N, Liu YC, McCullough AJ (1999) Nonalcoholic fatty liver disease: a spectrum of clinical and pathological severity. Gastroenterology 116: 1413-1419
16. Maher JJ (2002) Alcoholic steatosis and steatohepatitis. Sem Gastrointest Dis 13: 31-39
17. Bataille V, Ruidavets JB, Arveiler D, Amouyel P, Ducimetiere P, Perret B, et al (2003) Joint use of clinical parameters, biological markers and CAGE questionnaire for the identification of heavy drinkers in a large population-based sample. Alcohol Alcohol 38: 121-127
18. Yersin B, Nicolet JF, Dercrey H, Burnier M, van Melle G, Pecoud A (1995) Screening for excessive alcohol drinking. Comparative value of carbohydrate-deficient transferrin, gamma-glutamyltransferase, and mean corpuscular volume. Arch Intern Med 155: 1907-1911
19. Eriksen J, Olsen PS, Thomsen AC (1984) Gamma-glutamyltranspeptidase, aspartate aminotransferase, and erythrocyte mean corpuscular volume as indicators of alcohol consumption in liver disease. Scand J Gastroenterol 19: 813-819
20. Schöniger-Hekele M, Ramskogler K, Hartl D, Lesch OM, Müller C (2006) Exclusion of trisialo-transferrin from carbohydrate-deficient transferrin measurement: advantage in patients with chronic liver disease? Wien Med Wochenschr 156: 216-222
21. McCullough AJ (1999) Alcoholic liver disease. In: Schiff ER, Sorell MF, Maddrey WC (eds) Schiff's diseases of the liver, 8th edn. Lippincott-Raven, Philadelphia, pp 942-971
22. Rosman AS, Lieber CS (1994) Diagnostic utility of laboratory tests in alcoholic liver disease. Clin Chem 40: 1641-1651
23. Obesity: preventing and managing the global epidemic: report of a WHO Consultation on Obesity, Geneva, June 3-5, 1997. World Health Organization, Geneva 1988
24. Anderson P (1990) Management of drinking problems. WHO Reg Publ Eur Ser 32: 1-168
25. Health Education Council (publisher) (1994): That's the limit. London
26. Brunt EM, Janney CG, Di Bisceglie AM, Neuschwander-Tetri BA, Bacon BR (1999) Nonalcoholic steatohepatitis: a proposal for grading and staging the histological lesions. Am J Gastroenterol 94: 2467-2474
27. Searle J, Kerr JFR, Halliday JW, et al (1994) Iron storage disease. In: MacSween RNM, Anthony PP, Scheuer PJ, Burt AD, Portmann BC (eds) Pathology of the liver. Churchill Livingstone, London, p 224
28. Williams AL, Hoofnagle JH (1988) Ratio of serum aspartate to alanine aminotransferase in chronic hepatitis. Relationship to cirrhosis. Gastroenterology 95: 734-739
29. Nyblom H, Berggren U, Balldin J, Olsson R (2004) High AST/ALT ratio may indicate advanced alcoholic liver disease rather than heavy drinking. Alcohol Alcohol 39: 336-339
30. Giannini E, Risso D, Botta F, Chiarbonello B, Fasoli A, Malfatti F, et al (2003) Validity and clinical utility of the aspartate aminotransferase-alanine aminotransferase ratio in assessing disease severity and prognosis in patients with hepatitis C virus-related chronic liver disease. Arch Intern Med 163: 218-224
31. Clark JM (2006) The epidemiology of nonalcoholic fatty liver disease in adults. J Clin Gastroenterol 40: S5-S10
32. Maruyama S, Hirayama C, Yamamoto S, Koda M, Udagawa A, Kadowaki Y, et al (2001) Red blood cell status in alcoholic and non-alcoholic liver disease. J Lab Clin Med 138: 332-337
33. Morgan MY, Camilo ME, Luck W, Sherlock S, Hoffbrand AV (1981) Macrocytosis in alcohol-related liver disease: its value for screening. Clin Lab Haematol 3: 35-44
34. Thabut D, Naveau S, Charlotte F, Massard J, Ratziu V, Imbert-Bismut F, et al (2006) The diagnostic value of biomarkers (Ash test) for the prediction of alcoholic steatohepatitis in patients with chronic alcoholic liver disease. J Hepatol 44: 1175-1185
35. Dunn W, Angulo P, Sanderson S, Jamil LH, Stadheim L, Rosen C, et al (2006) Utility of a new model to diagnose an alcohol basis for steatohepatitis. Gastroenterology 131: 1057-1063
36. Hofer H, Osterreicher C, Jessner W, Penz M, Steindl-Munda P, Wrba F, et al (2004) Hepatic iron concentration does not predict response to standard and pegylated-IFN/ribavirin therapy in patients with chronic hepatitis C. J Hepatol 40: 1018-1022